Thank you for your interest, we’ll get in touch with you shortly!
Cognes is developing a scalable screening tool utilizing machine learning technology to identify digital biomarkers of dementia at an early stage, a smartphone-based solution to tackle today’s time-consuming and costly diagnostic process. There is great need for scalable, non-invasive and cost-effective digital solutions to stratify patient recruitments for clinical trials and accelerate disease-modifying drugs to get to the market.
We bring digitalization to the elderly in carehomes and any home. With sensors we help to make daily life more secure when you get older and your body cant be trusted.
Founded in 2018, MedBeat excels in creating advanced cardiac devices, aiming to lower global stroke and sudden cardiac death rates through continuous heart rhythm monitoring. Currently, they’re prioritizing growth, certifications, and market reach, powered by a nine-member team skilled in healthcare and tech.